Faricimab Quarterly Maintenance for Neovascular Age Related Macular Degeneration

Clinical trial NCT06742307 · RECRUITING

Trial details

NCT number: NCT06742307
Sponsor: Hospital Authority, Hong Kong
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Macular Degeneration Choroidal Neovascularization

Start date: 2025-08-21
Primary completion: 2026-10-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.